Our thoughts are with everyone feeling the impacts of the coronavirus pandemic. As the world adjusts to a new—and hopefully temporary—way of life, lawmakers in Washington are scrambling to keep the economic and public health consequences from spiraling out of control. Consistent with any major crisis, the next several weeks, if not months, will see nearly all other policymaking grind to a halt as resources (time, personnel, and money) are diverted appropriately to tackling the challenge before us.
This leaves many unknowns about the fate of science funding and policymaking for the foreseeable future. In response, COSSA has decided to transition its Social Science Advocacy Day, originally designed as a “fly-in” for advocates to meet with lawmakers on Capitol Hill, into a “phone-in.” In addition, we elected to delay the Advocacy Day phone-in by one month to April 27-28, 2020. If you are registered for Social Science Advocacy Day and have not been contacted by the COSSA team about these changes, please contact me.
We have outlined below some of the latest developments related to funding and policy important to the social and behavioral science community in the wake of the COVID-19 pandemic. Additional Congressional, Federal Agency, and community updates are also provided.
Finally, we recognize that in these trying times, the activities of Washington might be the farthest from your mind. We will continue to work on behalf of the social science research community during this uncertain time and report on new developments. But more importantly, we hope you will take care of yourself, your family, and your community.
COSSA Executive Director
Congressional leaders have been busy working to address the COVID-19 outbreak. On March 6, the President signed into law an $8.3 billion emergency spending bill to address the pandemic. The funding measure included support for state and local health agencies, vaccine and treatment development, and loans for affected small business. More emergency funding and policy measures are expected from Congress.
The outlook for Congressional productivity, particularly on annual appropriations, is uncertain. On March 12, the House and Senate Sergeant at Arms directed the Capitol, as well as the House and Senate Office Buildings to be closed to the public and many Congressional offices have moved to working remotely.
It is too early to tell how the pandemic will affect science funding next year, let alone federal research support this year (check out the next section on how federal agencies are responding to the coronavirus). The COVID-19 crisis coupled with the upcoming Presidential election all but guarantees that fiscal year 2021 will begin on October 1 under a cloud of uncertainty and very likely a continuing resolution.
Federal research agencies such as the National Science Foundation (NSF) and the National Institutes of Health (NIH) have released a series of informational documents and Frequently Asked Questions (FAQ) about the COVID-19 pandemic and how it affects daily research functions at those agencies.
The NIH FAQ includes links to the most recent information available about how the epidemic will affect practices for existing research awards, affect future awards, how NIH can assist funded researchers with sunk costs for travel or conference fees, and how to best impose isolation in larger research institutions.
The NSF FAQ offers similar information about changes to research practices, but also includes several pieces of information about coronavirus research funding opportunities. NSF has released a Dear Colleague Letter providing guidance on submitting research proposals seeking to treat or prevent the spread of the COVID-19 coronavirus. The NSF Dear Colleague Letter states that research proposals related to COVID-19 may be submitted through existing funding opportunities at NSF, but also invites submissions through the Rapid Response Research (RAPID) funding mechanism for quick-response and time-sensitive events. The NSF FAQ offers additional information about the logistics and special considerations of these coronavirus research proposals. The Dear Colleague Letter and more information about RAPID is available on the NSF website.
General COVID-19 Resources:
Federal Agency Resources:
Back to this issue’s table of contents.